We read the article by Kerzoncuf et al
1
with great interest. We appreciate the authors’ efforts to assess the effects of
injecting botulinum toxin type A (BTX-A) into the lower limb muscles of people with
hemiparesis post stroke. However, we have 2 concerns that may alter their conclusion.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Poststroke postural sway improved by botulinum toxin: a multicenter randomized double-blind controlled trial.Arch Phys Med Rehabil. 2020; 101: 242-248
- Comparisons against baseline within randomized groups are often used and can be highly misleading.Trials. 2011; 12: 264
Article info
Publication history
Published online: August 20, 2020
Footnotes
Disclosures: none.
Identification
Copyright
© 2020 by the American Congress of Rehabilitation Medicine
